Partner Investment Management, L.P. is an investment fund managing more than $13.9 million ran by Darin Sadow. There are currently 41 companies in Mrs. Sadow’s portfolio. The largest investments include Audentes Therapeutics Inc and Alexion Pharmaceuticals, together worth $1.98 million.
As of 7th October 2020, Partner Investment Management, L.P.’s top holding is 17,795 shares of Audentes Therapeutics Inc currently worth over $1.07 million and making up 7.6% of the portfolio value.
In addition, the fund holds 8,421 shares of Alexion Pharmaceuticals worth $911 thousand, whose value grew 24.5% in the past six months.
The third-largest holding is Allena Pharmaceuticals worth $776 thousand and the next is Gilead Sciences worth $708 thousand, with 10,898 shares owned.
Currently, Partner Investment Management, L.P.'s portfolio is worth at least $13.9 million. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Partner Investment Management, L.P. office and employees reside in San Francisco, California. According to the last 13-F report filed with the SEC, Darin Sadow serves as the General Counsel and Chief Compliance Officer at Partner Investment Management, L.P..
In the most recent 13F filing, Partner Investment Management, L.P. revealed that it had opened a new position in
Biogen and bought 1,839 shares worth $546 thousand.
This means they effectively own approximately 0.1% of the company.
Biogen makes up
5.2%
of the fund's Health Care sector allocation and has grown its share price by 29.1% in the past year.
The investment fund also strengthened its position in Aerie Pharmaceuticals by buying
1,304 additional shares.
This makes their stake in Aerie Pharmaceuticals total 18,035 shares worth $436 thousand.
Aerie Pharmaceuticals dropped 41.2% in the past year.
On the other hand, there are companies that Partner Investment Management, L.P. is getting rid of from its portfolio.
Partner Investment Management, L.P. closed its position in Novo-nordisk A S on 14th February 2020.
It sold the previously owned 17,526 shares for $6.17 million.
Darin Sadow also disclosed a decreased stake in Audentes Therapeutics Inc by 0.3%.
This leaves the value of the investment at $1.07 million and 17,795 shares.
The two most similar investment funds to Partner Investment Management, L.P. are Context Capital Management and Cpv Partners. They manage $13.9 million and $13.8 million respectively.
Partner Investment Management, L.P.’s portfolio is diversified across 2 sectors.
Currently, their heaviest sector is Health Care — making up 76.0% of
the total portfolio value.
The fund focuses on investments in the United States as
70.7% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
46% of the total holdings value.
On the other hand, small-cap stocks make up only 7.3% of the portfolio.
The average market cap of the portfolio companies is close to $38.7 billion.
These positions were updated on February 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Novo-nordisk A S |
Closed
17,526
|
$6,172,000 | |
| Nxp Semiconductors N V |
Closed
20,473
|
$2,234,000 | |
| Microchip Technology, Inc. |
Closed
23,996
|
$2,229,000 | |
| Twilio, Inc. |
Closed
15,783
|
$1,735,000 | |
| Western Digital Corp. |
Closed
26,326
|
$1,570,000 | |
| Intuit, Inc. |
Closed
5,722
|
$1,522,000 | |
| salesforce.com, inc. |
Closed
10,032
|
$1,489,000 | |
| GoDaddy, Inc. |
Closed
21,910
|
$1,446,000 | |
| Wellcare Health Plans Inc |
Closed
4,757
|
$1,233,000 | |
| Audentes Therapeutics Inc |
29.86%
17,795
|
$1,065,000 | 7.65% |
| Microsoft Corp. |
Closed
7,383
|
$1,026,000 | |
| Alexion Pharmaceuticals, Inc. |
61.96%
8,421
|
$911,000 | 6.54% |
| Stryker Corp. |
Closed
3,728
|
$806,000 | |
| Mks Instrument Inc |
Closed
8,701
|
$803,000 | |
| DexCom, Inc. |
Closed
5,323
|
$794,000 | |
| Allena Pharmaceuticals, Inc. |
No change
284,285
|
$776,000 | 5.57% |
| MyoKardia, Inc. |
Closed
14,720
|
$768,000 | |
| Visa, Inc. |
Closed
4,427
|
$761,000 | |
| Advanced Micro Devices, Inc. |
Closed
25,859
|
$750,000 | |
| Gilead Sciences, Inc. |
61.76%
10,898
|
$708,000 | 5.08% |
| PTC Therapeutics, Inc. |
Closed
20,028
|
$677,000 | |
| Twitter, Inc. |
Closed
15,797
|
$651,000 | |
| Coupa Software, Inc. |
Closed
4,773
|
$618,000 | |
| Penumbra, Inc. |
70.54%
3,699
|
$608,000 | 4.37% |
| SAGE Therapeutics, Inc. |
Closed
4,267
|
$599,000 | |
| uniQure NV |
Closed
14,711
|
$579,000 | |
| Zimmer Biomet Holdings, Inc. |
79.14%
3,689
|
$552,000 | 3.96% |
| Biogen, Inc. |
Opened
1,839
|
$546,000 | 3.92% |
| Nevro Corp. |
21.71%
4,515
|
$531,000 | 3.81% |
| Anthem Inc |
Opened
1,669
|
$504,000 | 3.62% |
| Humana, Inc. |
Opened
1,347
|
$494,000 | 3.55% |
| Cigna Corp. |
68.93%
2,216
|
$453,000 | 3.25% |
| IQVIA Holdings, Inc. |
65.85%
2,926
|
$452,000 | 3.25% |
| BioMarin Pharmaceutical, Inc. |
81.84%
5,329
|
$451,000 | 3.24% |
| Allergan Plc |
69.05%
2,282
|
$436,000 | 3.13% |
| Aerie Pharmaceuticals, Inc. |
7.79%
18,035
|
$436,000 | 3.13% |
| Live Nation Entertainment In |
Closed
6,525
|
$433,000 | |
| Arena Pharmaceuticals, Inc. |
67.16%
9,484
|
$431,000 | 3.09% |
| Centene Corp. |
Opened
6,838
|
$430,000 | 3.09% |
| Alibaba Group Hldg Ltd |
Closed
2,532
|
$423,000 | |
| Mirati Therapeutics, Inc. |
Closed
5,370
|
$418,000 | |
| Visteon Corp. |
Closed
4,944
|
$408,000 | |
| Novartis A G |
60.13%
4,270
|
$392,000 | 2.81% |
| Puma Biotechnology, Inc. |
Closed
33,866
|
$365,000 | |
| HCA Healthcare, Inc. |
68.87%
2,335
|
$345,000 | 2.48% |
| The Goldman Sachs Group, Inc. |
Closed
1,562
|
$324,000 | |
| Pfizer Inc. |
Opened
7,492
|
$294,000 | 2.11% |
| Icu Med Inc |
Opened
1,381
|
$258,000 | 1.85% |
| Dermira Inc |
43.69%
16,892
|
$256,000 | 1.84% |
| ICON plc |
56.35%
1,402
|
$241,000 | 1.73% |
| UnitedHealth Group, Inc. |
Opened
791
|
$233,000 | 1.67% |
| iRhythm Technologies, Inc. |
73.44%
3,389
|
$231,000 | 1.66% |
| Immunomedics, Inc. |
Opened
10,880
|
$230,000 | 1.65% |
| Abbott Labs |
Opened
2,565
|
$223,000 | 1.60% |
| Inspire Med Sys Inc |
Closed
3,549
|
$217,000 | |
| Voyager Therapeutics, Inc. |
Closed
11,378
|
$196,000 | |
| Delphi Technologies Plc |
Closed
14,179
|
$190,000 | |
| Molina Healthcare, Inc. |
80.69%
1,387
|
$188,000 | 1.35% |
| Edwards Lifesciences Corp. |
78.81%
788
|
$184,000 | 1.32% |
| Fate Therapeutics, Inc. |
Closed
8,899
|
$138,000 | |
| Fluidigm Corp. |
7.08%
37,856
|
$132,000 | 0.95% |
| Catalent, Inc. |
83.55%
2,231
|
$126,000 | 0.90% |
| MorphoSys AG |
Opened
994
|
$126,000 | 0.90% |
| AbbVie, Inc. |
Opened
1,269
|
$112,000 | 0.80% |
| Axonics Modulation Tech Inc |
105.37%
3,978
|
$110,000 | 0.79% |
| Cardiovascular Sys Inc Del |
66.44%
1,985
|
$96,000 | 0.69% |
| Vertex Pharmaceuticals, Inc. |
Opened
434
|
$95,000 | 0.68% |
| Halozyme Therapeutics, Inc. |
Opened
4,650
|
$82,000 | 0.59% |
| Amarin Corp. Plc |
Opened
3,757
|
$81,000 | 0.58% |
| Tradeweb Mkts Inc |
Closed
2,132
|
$79,000 | |
| Coherus BioSciences, Inc. |
51.69%
3,771
|
$68,000 | 0.49% |
| Avrobio, Inc. |
Closed
4,669
|
$66,000 | |
| Acorda Therapeutics, Inc. |
7.73%
18,342
|
$37,000 | 0.27% |
| Assetmark Finl Hldgs Inc |
Closed
961
|
$25,000 | |
| Livongo Health, Inc. |
Closed
1,444
|
$25,000 | |
| Eidos Therapeutics, Inc. |
Closed
607
|
$22,000 | |
| Equillium, Inc. |
Closed
5,333
|
$20,000 | |
| Endologix, Inc. |
15.34%
2,440
|
$4,000 | 0.03% |
| No transactions found | |||
| Showing first 500 out of 78 holdings | |||